News & Events

Why AbbVie is a member of Vivli

Research and innovation are the cornerstones of AbbVie’s business. The company advances leading-edge science through a dynamic and collaborative approach, enabling them to find better solutions for treating the world’s most challenging diseases. AbbVie focuses on discovering, developing and delivering medicines in therapeutic areas where it has proven expertise and can make an impact. This includes Immunology, Oncology, Neuroscience, Virology and General Medicine.

A Commitment to Data and Information Sharing

There are important health benefits in making clinical trial data and information available to health care providers, researchers, patients and the general public. Thus, AbbVie has adopted national and international principles and standards regarding the sharing and publication of clinical trials data and information.

“We are committed to responsible and ethical clinical trial data sharing and believe in its potential to advance scientific knowledge to improve patient care,” said Rob Scott, M.D., chief medical officer and vice president, global pharmaceutical development, AbbVie. “Our collaboration with Vivli supports this commitment and we look forward to a successful partnership and broad uptake of this unique and global platform.”

Find out more about how to access and request AbbVie studies on Vivli.